Clinical Trials on Monocytosis
Total 1 results
-
Corporacion Parc TauliUnknownRenal Cell Carcinoma | Progression | Lymphocyte Disorder | Monocytosis | Local DiseaseSpain
Sponsors and Collaborators
- The Fifth Affiliated Hospital of Zunyi Medical College
- San MediTech(Huzhou)Co.,Ltd.
- Norsk Proteinintolerance, Norway
- Diego Hernan Giunta, MD
- ProteoSys AG
- Societa Italiana di Endoscopia Digestiva
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Victor Montori
- Rui-hua Xu, MD, PhD
- Caritas Freetown
- University Medical Center Goettingen
- Cardresearch
- Celtaxsys Aus Pty Limited
- CRMBM-CEMEREM
- Elim Pediatric Pharmaceuticals Inc.
- Alberta Children's Hospital, Calgary, Canada
- Fondren Orthopedic Group L.L.P.
- AMTC & Associates
- Donders Institute for Brain, Cognition and Behavior
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- View Full List
Medical Conditions
- Lymphedema of Arm
- Gynecologic Cancer
- Fever, Sweats, and Hot Flashes
- Non-dystrophic Myotonias
- Plasmodium Falciparum Malaria (Drug Resistant)
- Spermatogenesis Arrest
- Orbital Tumor
- Tularaemia
- Non-compressible Torso Hemorrhage
- Postcomatose Unawareness State
- Normal Diameter of Optic Nerve
- Stereotactic Radioablation for Ventricular Tachycardia
- Malignant Ascites Due to Epithelial Carcinoma
- Tube Disorders Eustachian
- Fibromyalgia Syndrome, Primary
- Prostate Cancer Recurrent
- Disturbance of Activity and Attention
- Auditory Hallucination, Verbal
- Atrial Fibrillation, Postoperative
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- View Full List
Drug Interventions
- Methotrexate
- Topotecan
- Lamivudine
- Ruxolitinib
- Epimedium Prenylflavonoids Extract
- Oxycodone, fentanyl
- Cytarabine ARA-C
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- Enzalutamide, Abiraterone
- Bortezomib/dexamethasone
- Flibanserin 100 mg dose every evening
- Insulin
- Atezolizumab
- Polyethylene glycol 3350
- SERETIDE Diskus
- Mupirocin Calcium
- Cetrorelix 78 mg + 78 mg
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- PF-00868554
- Indoximod
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Brazil
- Contract Research Organizations in Egypt
- Contract Research Organizations in Estonia
- Contract Research Organizations in Gambia
- Contract Research Organizations in Japan
- Contract Research Organizations in Norway
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Spain
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Venezuela
- CRO list by country